Dr Reddy's Q4 net profit rises 21% to Rs 1,587 crore on strong global sales / Dr Reddy's, Hetero ink royalty-free pact with Gilead / Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir / Dr Reddy's inks licencing pact with Ingenus Pharma for cancer drug / Biologics facility of Dr Reddy's CRDMO arm Aurigene opened / Dr Reddy's inks licencing agreement with Alvotech / Dr Reddy's, Alvotech ink licencing pact for commercialising denosumab biosimilar / KCR didn't fulfil promises, Modi selling PSUs, says Jagga Reddy / Dr Reddy's to exclusively distribute Sanofi's vaccine portfolio in India / Dr Reddy's acquires MenoLabs women's wellness portfolio from Amyris